Innogen · News · July 4, 2013

Innogen Weekly News Roundup (29/06/13 - 04/07/13)

Innogen Weekly News Roundup (29/06/13 - 04/07/13)

All the latest news from around the world on the life sciences and emerging technologies.

A weekly roundup of global news on topics, including: agriculture, the bioeconomy, food and energy security, genes and genomics, global health and development, healthcare, innovation systems, pharma, synthetic biology, science and technology.

Agriculture

Genes Found to Fight Wheat Disease (Voice of America)

Food & Energy Security

White House On Food Security in Sub-Saharan Africa (All Africa)

Agro Forestry Greatly Improves Food Security (All Africa)

Defra urges UK to adapt to climate change (Resource)

Genes & Genomics

UK becomes first country in world to approve IVF using genes of three parents (The Independent)

Your DNA vulnerable to snooping, too? (USA Today)

Human genetics: life science (Guardian)

Genomes for science, genomes for life, and genomes for you and me (Phys.org)

The firms putting a copyright on cancer (Telegraph)

Global Health & Development

Tackling drug resistant malaria: one step forward, two steps back? (Guardian)

Technology and global development: Q&A with Helen Clark, UNDP (Guardian)

Five Big Ideas for the Global Struggle Against Fake Medicines (Huffington Post)

Patents keep HIV drugs too pricy (Herald Sun)

HIV Drug Patents: Developing Countries Losing Out On Newer Drugs, Activists Say (Huffington Post)

Encourage countries to strengthen their own health systems, DfID told (Guardian)

Healthcare

EU at crossroad on new medical devices legislation (EurActiv)

UK underprepared for benefits of regenerative medicine, warn Lords (Pharma Times)

Stem-cell therapy wipes out HIV in two patients (Reuters)

Scientists Grow Human Liver From Stem Cells, With Promise of Regenerative Medicine Within A Decade (Medical Daily)

US doctors look with envy at Europe’s medical devices approval scheme (EurActiv)

Pharma

A Landmark For Biosimilars: EU Endorses Copies of A J&J Drug (Forbes)

Research and Markets: Are Biosimilars Too Expensive for Emerging Economies (Wall Street Journal)

Research and Markets: Biosimilar Defensive Plays – Assessing the Options (Wall Street Journal)

Science & Technology

Creating a more diverse future for biomedicine (Phys.org)

Mimicking living cells: Synthesizing ribosome (Phys.org)

Innogen Associates

Marianna Mazzucato: Getting At The One True Rule Of Innovation (Forbes)